Related references
Note: Only part of the references are listed.Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals
Milena Cavic et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)
Modulation of single cell circadian response to NMDA by diacylglycerol lipase inhibition reveals a role of endocannabinoids in light entrainment of the suprachiasmatic nucleus
Martin Sladek et al.
NEUROPHARMACOLOGY (2021)
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
Tamara T. Lah et al.
CELLS (2021)
Metabolomics study reveals the potential evidence of metabolic reprogramming towards the Warburg effect in precancerous lesions
Xun Chen et al.
JOURNAL OF CANCER (2021)
Reprogramming of fatty acid metabolism in cancer
Nikos Koundouros et al.
BRITISH JOURNAL OF CANCER (2020)
Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
Alan Talevi et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
The Endocannabinoid System: A Target for Cancer Treatment
Chiara Laezza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro
Lara Milian et al.
PLOS ONE (2020)
A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction
Laura Domingo-Rodriguez et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
Siddappa N. Byrareddy et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
Cecilia T. Costiniuk et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Vicente Martinez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
Patrycja Bielawiec et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Emerging therapeutic agents for advanced non-small cell lung cancer
Ruqin Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
Marialessandra Contino et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Double-Faced Role of Nitric Oxide and Reactive Oxygen Species in Solid Tumors
Sanja Mijatovic et al.
ANTIOXIDANTS (2020)
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
Dongchen An et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back
Osnat Almogi-Hazan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
Thomas Murphy et al.
BIOMOLECULES (2020)
The Immune Endocannabinoid System of the Tumor Microenvironment
Melanie Kienzl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Expression of endocannabinoid system components in human airway epithelial cells: impact of sex and chronic respiratory disease status
Matthew F. Fantauzzi et al.
ERJ OPEN RESEARCH (2020)
The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment
Estefania Moreno et al.
CANCERS (2020)
Challenges for Drug Repurposing in the COVID-19 Pandemic Era
Janet Sultana et al.
FRONTIERS IN PHARMACOLOGY (2020)
Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment
Theodore S. Kapellos et al.
FASEB JOURNAL (2019)
Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation
Iman Khuja et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
TLR4 Receptor Induces 2-AG-Dependent Tolerance to Lipopolysaccharide and Trafficking of CB2 Receptor in Mast Cells
Zyanya P. Espinosa-Riquer et al.
JOURNAL OF IMMUNOLOGY (2019)
Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer
Sandra Blasco-Benito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefania Moreno et al.
FRONTIERS IN PHARMACOLOGY (2019)
Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and its Downstream Signaling Pathways in Metastatic Colorectal Cancer
Valeria Tutino et al.
CANCERS (2019)
Endocannabinoid and Prostanoid Crosstalk in Pain
Baptiste Buisseret et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells
Kathryn Miranda et al.
FRONTIERS IN IMMUNOLOGY (2019)
Emerging class of omega-3 fatty acid endocannabinoids & their derivatives
Josephine E. Watson et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus
Alain Veilleux et al.
CURRENT DIABETES REPORTS (2019)
Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
Vincenzo Di Marzo et al.
NUTRIENTS (2019)
Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma
Francieli Vuolo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool
Milena Cavic et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Endocannabinoid System in the Airways
Turgut Emrah Bozkurt
MOLECULES (2019)
Anti-inflammatory mechanisms of cannabinoids: an immunometabolic perspective
G. van Niekerk et al.
INFLAMMOPHARMACOLOGY (2019)
Association Between Marijuana Use and Risk of Cancer A Systematic Review and Meta-analysis
Mehrnaz Ghasemiesfe et al.
JAMA NETWORK OPEN (2019)
Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics
Jelena Grahovac et al.
CANCER BIOLOGY & MEDICINE (2019)
Cannabis-Associated Asthma and Allergies
J. M. Chatkin et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1
Carina Hasenoehrl et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice
Alireza Tahamtan et al.
VIRULENCE (2018)
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation
Sevil Kose et al.
EXPERIMENTAL HEMATOLOGY (2018)
Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration
Kisha A. Scarlett et al.
MOLECULAR CANCER RESEARCH (2018)
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
Valerio Chiurchiu et al.
PROGRESS IN NEUROBIOLOGY (2018)
Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression
Wei Xiang et al.
NATURE COMMUNICATIONS (2018)
Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis
Rose L. Szabady et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress
Ali Parlar et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Medical Use of Cannabinoids
Ana Isabel Fraguas-Sanchez et al.
DRUGS (2018)
Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
Kazuhito Tsuboi et al.
INFLAMMATION AND REGENERATION (2018)
CB2R agonist prevents nicotine induced lung fibrosis
Ewelina Wawryk-Gawda et al.
EXPERIMENTAL LUNG RESEARCH (2018)
Synthetic Cannabinoid Activity Against Colorectal Cancer Cells
Wesley M. Raup-Konsavage et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
MECHANISMS IN ENDOCRINOLOGY Endocannabinoids and metabolism: past, present and future
Vincent Simon et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Cytotoxic activity of Nepeta rtanjensis Diklic & Milojevic essential oil and its mode of action
Marijana Skoric et al.
INDUSTRIAL CROPS AND PRODUCTS (2017)
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis
Ester Pagano et al.
PHARMACOLOGICAL RESEARCH (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
T. Srdic-Rajic et al.
SCIENTIFIC REPORTS (2017)
Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis
Resat Cinar et al.
JCI INSIGHT (2017)
Role of the endocannabinoid system in diabetes and diabetic complications
G. Gruden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
Rosaria I. Staiano et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
被撤回的出版物: Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo (Retracted article. See vol. 27, 2023)
Chao Ma et al.
MOLECULAR MEDICINE REPORTS (2016)
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity
A. M. Monteleone et al.
EUROPEAN JOURNAL OF NUTRITION (2016)
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
A. I. Fraguas-Sanchez et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression
Christopher J. Coke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway
Janani Ravi et al.
MOLECULAR CARCINOGENESIS (2016)
The endogenous cannabinoid anandamide increases human airway epithelial cell permeability through an arachidonic acid metabolite
V. C. M. Shang et al.
PHARMACOLOGICAL RESEARCH (2016)
FROM PHYTOCANNABINOIDS TO CANNABINOID RECEPTORS AND ENDOCANNABINOIDS: PLEIOTROPIC PHYSIOLOGICAL AND PATHOLOGICAL ROLES THROUGH COMPLEX PHARMACOLOGY
Alessia Ligresti et al.
PHYSIOLOGICAL REVIEWS (2016)
Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools
Giorgia Macedonio et al.
PROTEIN AND PEPTIDE LETTERS (2016)
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans
Jonathan Cedernaes et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Disturbances of sleep and circadian rhythms: novel risk factors for obesity
Josiane L. Broussard et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2016)
CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
Esther Martinez-Martinez et al.
ONCOTARGET (2016)
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea
Xiaoya Wang et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
Caroline Turcotte et al.
FRONTIERS IN PHARMACOLOGY (2016)
Endocannabinoid signalling in innate and adaptive immunity
Valerio Chiurchiu et al.
IMMUNOLOGY (2015)
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
Caroline Turcotte et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
Sean D. McAllister et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans
Ilario Mennella et al.
JOURNAL OF NUTRITION (2015)
Proapoptotic effect of endocannabinoids in prostate cancer cells
O. Orellana-Serradell et al.
ONCOLOGY REPORTS (2015)
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture
Katarzyna Malenczyk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Epidemiology of Obesity: A Big Picture
Adela Hruby et al.
PHARMACOECONOMICS (2015)
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor
Valerio Chiurchiu et al.
ATHEROSCLEROSIS (2014)
Hepatic Cannabinoid-1 Receptors Mediate Diet-Induced Insulin Resistance by Increasing De Novo Synthesis of Long-Chain Ceramides
Resat Cinar et al.
HEPATOLOGY (2014)
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefania Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The endocannabinoid system controls food intake via olfactory processes
Edgar Soria-Gomez et al.
NATURE NEUROSCIENCE (2014)
Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study
Joseph Abdulnour et al.
OBESITY (2014)
Pregnenolone Can Protect the Brain from Cannabis Intoxication
Monique Vallee et al.
SCIENCE (2014)
Sheep cheese naturally enriched in α-linolenic, conjugated linoleic and vaccenic acids improves the lipid profile and reduces anandamide in the plasma of hypercholesterolaemic subjects
Stefano Pintus et al.
BRITISH JOURNAL OF NUTRITION (2013)
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Cristoforo Silvestri et al.
CELL METABOLISM (2013)
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction
Rebecca Hartzell Robinson et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men
Kjetil Berge et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
Central functional response to the novel peptide cannabinoid, hemopressin
Garron T. Dodd et al.
NEUROPHARMACOLOGY (2013)
Cannabinoids: A new hope for breast cancer therapy?
Maria M. Caffarel et al.
CANCER TREATMENT REVIEWS (2012)
Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Joseph Tam et al.
CELL METABOLISM (2012)
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Cristoforo Silvestri et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity
B. Gatta-Cherifi et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors
Mark Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Hedonic Eating Is Associated with Increased Peripheral Levels of Ghrelin and the Endocannabinoid 2-Arachidonoyl-Glycerol in Healthy Humans: A Pilot Study
Palmiero Monteleone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
Sean D. McAllister et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Tumor cell metabolism An integral view
Susana Romero-Garcia et al.
CANCER BIOLOGY & THERAPY (2011)
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
Anju Preet et al.
CANCER PREVENTION RESEARCH (2011)
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
Nariman A. B. Balenga et al.
CELL RESEARCH (2011)
Central and Peripheral Endocannabinoids and Cognate Acylethanolamides in Humans: Association with Race, Adiposity, and Energy Expenditure
Reiner Jumpertz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation
Ravi Murumalla et al.
JOURNAL OF INFLAMMATION-LONDON (2011)
Production of functional recombinant G-protein coupled receptors for heteromerization studies
Milena Cavic et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion
Mohd W. Nasser et al.
PLOS ONE (2011)
Rimonabant: FromRIO to Ban
Amir H. Sam et al.
JOURNAL OF OBESITY (2011)
Ghrelin Increases the Rewarding Value of High-Fat Diet in an Orexin-Dependent Manner
Mario Perello et al.
BIOLOGICAL PSYCHIATRY (2010)
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
N. L. Cluny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver The Role of eNOS, p38 MAPK, and AMPK Pathways
Laura Tedesco et al.
DIABETES (2010)
Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes
N. Perwitz et al.
DIABETES OBESITY & METABOLISM (2010)
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
J. Agudo et al.
DIABETOLOGIA (2010)
The Levels of the Endocannabinoid Receptor CB2 and Its Ligand 2-Arachidonoylglycerol Are Elevated in Endometrial Carcinoma
Maurizio Guida et al.
ENDOCRINOLOGY (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice
Garron T. Dodd et al.
JOURNAL OF NEUROSCIENCE (2010)
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Maria M. Caffarel et al.
MOLECULAR CANCER (2010)
Cannabidiol Enhances the Inhibitory Effects of Delta(9)-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Jahan P. Marcu et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking
J. Hoggatt et al.
LEUKEMIA (2010)
Bimodal control of stimulated food intake by the endocannabinoid system
Luigi Bellocchio et al.
NATURE NEUROSCIENCE (2010)
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
F. J. Bermudez-Silva et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Endocannabinoids selectively enhance sweet taste
Ryusuke Yoshida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effect of Rimonabant on the High-Triglyceride/Low-HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat The ADAGIO-Lipids Trial
Jean-Pierre Despres et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The role of the endocannabinoid system in lipogenesis and fatty acid metabolism
Roberto Vettor et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2
N. Olea-Herrero et al.
BRITISH JOURNAL OF CANCER (2009)
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects
Vincenzo Di Marzo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Cannabinoid Receptor Type 1-and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling
Christine Boerner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
Zahida Qamri et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids
Joao P. Pereira et al.
NATURE IMMUNOLOGY (2009)
Anandamide Increases the Differentiation of Rat Adipocytes and Causes PPARγ and CB1 Receptor Upregulation
Sevasti Karaliota et al.
OBESITY (2009)
Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes
M. Gallant et al.
PHYTOMEDICINE (2009)
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
Vanessa Deveaux et al.
PLOS ONE (2009)
Therapeutic potential of cannabis in pain medicine
R. D. Hosking et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease -: The STRADIVARIUS randomized controlled trial
Steven E. Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Cannabinoid-mediated neuroprotection, not immuno suppression, may be more relevant to multiple sclerosis
J. Ludovic Croxford et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms
Christoph Buettner et al.
NATURE MEDICINE (2008)
Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription
Christine Boerner et al.
NEUROIMMUNOMODULATION (2008)
The complications of promiscuity: endocannabinoid action and metabolism
S. P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
Andrea S. Heimann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms
Claudio Pagano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats
P. Janiak et al.
KIDNEY INTERNATIONAL (2007)
Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors
Toby K. Eisenstein et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Cannabinoids and gliomas
Guillermo Velasco et al.
MOLECULAR NEUROBIOLOGY (2007)
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men
M. Cote et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
Barbara Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
Isabel Matias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
Maria M. Caffarel et al.
CANCER RESEARCH (2006)
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
D Panikashvili et al.
NEUROBIOLOGY OF DISEASE (2006)
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake
I Matias et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
M Bouaboula et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein
GJM Maestroni
FASEB JOURNAL (2004)
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas
C Blázquez et al.
CANCER RESEARCH (2004)
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells
B Hinz et al.
MOLECULAR PHARMACOLOGY (2004)
Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide:: variability in response and involvement of arachidonic acid
CJ Fowler et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Cannabinoid receptors and their ligands
RG Pertwee et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Differential expression of cannabinoid CB2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation
SF Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Share Paper
